These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23176519)

  • 21. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.
    Faught E
    Expert Opin Investig Drugs; 2014 Jan; 23(1):107-13. PubMed ID: 24147649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for novel antiepileptic drugs.
    Avanzini G; Franceschetti S
    Curr Opin Investig Drugs; 2003 Jul; 4(7):805-14. PubMed ID: 14619401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigational small molecules in phase II clinical trials for the treatment of epilepsy.
    Greco M; Varriale G; Coppola G; Operto F; Verrotti A; Iezzi ML
    Expert Opin Investig Drugs; 2018 Dec; 27(12):971-979. PubMed ID: 30408428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate: New preparation. Helpful in refractory partial epilepsy.
    Prescrire Int; 1999 Feb; 8(39):3-5. PubMed ID: 10557563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.
    Zaccara G; Giovannelli F; Cincotta M; Iudice A
    Expert Rev Neurother; 2013 Jun; 13(6):647-55. PubMed ID: 23739002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology of new antiepileptic drugs.
    Willmore LJ
    Neurology; 2000; 55(11 Suppl 3):S17-24. PubMed ID: 11147564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for children and adolescents with epilepsy.
    Verrotti A; Loiacono G; Coppola G; Spalice A; Mohn A; Chiarelli F
    Expert Opin Pharmacother; 2011 Feb; 12(2):175-94. PubMed ID: 21208135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modern antiepileptic drugs: guidelines and beyond.
    Hitiris N; Brodie MJ
    Curr Opin Neurol; 2006 Apr; 19(2):175-80. PubMed ID: 16538093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data.
    Orhan G; Wuttke TV; Nies AT; Schwab M; Lerche H
    Expert Opin Pharmacother; 2012 Aug; 13(12):1807-16. PubMed ID: 22783830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction: Perampanel--new mode of action and new option for patients with epilepsy.
    Steinhoff BJ
    Epilepsia; 2014 Jan; 55 Suppl 1():1-2. PubMed ID: 24400689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabapentin.
    Chadwick D
    Epilepsy Res Suppl; 1991; 3():183-6. PubMed ID: 1777078
    [No Abstract]   [Full Text] [Related]  

  • 39. Should enzyme-inducing antiepileptic drugs be considered first-line agents?
    Mintzer S; Mattson RT
    Epilepsia; 2009 Sep; 50 Suppl 8():42-50. PubMed ID: 19702733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide in the treatment of epilepsy.
    Holder JL; Wilfong AA
    Expert Opin Pharmacother; 2011 Nov; 12(16):2573-81. PubMed ID: 21967409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.